Non-central nervous system pathology

Clinical trials for Non-central nervous system pathology explained in plain language.

Never miss a new study

Get alerted when new Non-central nervous system pathology trials appear

Sign up with your email to follow new studies for Non-central nervous system pathology, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New MRI dye could mean less gadolinium for patients

Diagnosis Completed

This study tested a new contrast agent called gadoquatrane for MRI scans of the body (excluding the brain and spine). The goal was to see if using a lower dose of gadolinium could still produce clear images. 404 adults with known or suspected health issues received two MRI scans:…

Matched conditions: NON-CENTRAL NERVOUS SYSTEM PATHOLOGY

Phase 3 • Sponsor: Bayer • Aim: Diagnosis

Last updated Aug 22, 2026 00:00 UTC

Non-central nervous system pathology

Get alerted when new Non-central nervous system pathology trials appear

New MRI dye could mean less gadolinium for patients